241 related articles for article (PubMed ID: 27045317)
1. Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Findlay JM; Castro-Giner F; Makino S; Rayner E; Kartsonaki C; Cross W; Kovac M; Ulahannan D; Palles C; Gillies RS; MacGregor TP; Church D; Maynard ND; Buffa F; Cazier JB; Graham TA; Wang LM; Sharma RA; Middleton M; Tomlinson I
Nat Commun; 2016 Apr; 7():11111. PubMed ID: 27045317
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.
Noorani A; Bornschein J; Lynch AG; Secrier M; Achilleos A; Eldridge M; Bower L; Weaver JMJ; Crawte J; Ong CA; Shannon N; MacRae S; Grehan N; Nutzinger B; O'Donovan M; Hardwick R; Tavaré S; Fitzgerald RC;
Genome Res; 2017 Jun; 27(6):902-912. PubMed ID: 28465312
[TBL] [Abstract][Full Text] [Related]
3. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
Murugaesu N; Wilson GA; Birkbak NJ; Watkins T; McGranahan N; Kumar S; Abbassi-Ghadi N; Salm M; Mitter R; Horswell S; Rowan A; Phillimore B; Biggs J; Begum S; Matthews N; Hochhauser D; Hanna GB; Swanton C
Cancer Discov; 2015 Aug; 5(8):821-831. PubMed ID: 26003801
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
[TBL] [Abstract][Full Text] [Related]
5. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
6. Rectal cancer sub-clones respond differentially to neoadjuvant therapy.
Frydrych LM; Ulintz P; Bankhead A; Sifuentes C; Greenson J; Maguire L; Irwin R; Fearon ER; Hardiman KM
Neoplasia; 2019 Oct; 21(10):1051-1062. PubMed ID: 31521947
[TBL] [Abstract][Full Text] [Related]
7. Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.
Obulkasim A; Ylstra B; van Essen HF; Benner C; Stenning S; Langley R; Allum W; Cunningham D; Inam I; Hewitt LC; West NP; Meijer GA; van de Wiel MA; Grabsch HI
Oncotarget; 2016 Jul; 7(28):44084-44095. PubMed ID: 27286451
[TBL] [Abstract][Full Text] [Related]
8. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
[TBL] [Abstract][Full Text] [Related]
9. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
[TBL] [Abstract][Full Text] [Related]
10. Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.
Oh HR; An CH; Yoo NJ; Lee SH
Pathol Oncol Res; 2017 Jan; 23(1):125-130. PubMed ID: 27571988
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
[TBL] [Abstract][Full Text] [Related]
12. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide relationships between TAF1 and histone acetyltransferases in Saccharomyces cerevisiae.
Durant M; Pugh BF
Mol Cell Biol; 2006 Apr; 26(7):2791-802. PubMed ID: 16537921
[TBL] [Abstract][Full Text] [Related]
14. A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Foley KG; Lavery A; Napier E; Campbell D; Eatock MM; Kennedy RD; Bradley KM; Turkington RC
Sci Rep; 2021 Jun; 11(1):13061. PubMed ID: 34158588
[TBL] [Abstract][Full Text] [Related]
15. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
16. Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
Takahashi K; Roh W; Zhang J; Propotopov A; Patel K; Strickland S; Kim A; Vnencak-Jones C; Pelletier S; Parmar S; Garcia-Manero G; Kornblau S; Chin L; Kantarjian H; Futreal PA; Ravandi F
Am J Hematol; 2015 Jul; 90(7):E134-5. PubMed ID: 25801490
[No Abstract] [Full Text] [Related]
17. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
[TBL] [Abstract][Full Text] [Related]
18. Congenital Heart Defects Due to
Morton SU; Agarwal R; Madden JA; Genetti CA; Brownstein CA; López-Giráldez F; Choi J; Seidman CE; Seidman JG; Lyon GJ; Agrawal PB
Circ Genom Precis Med; 2020 Jun; 13(3):e002843. PubMed ID: 32396742
[No Abstract] [Full Text] [Related]
19. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
Hilton TL; Li Y; Dunphy EL; Wang EH
Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
[TBL] [Abstract][Full Text] [Related]
20. Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations.
Isidori F; Bozzarelli I; Mastracci L; Malvi D; Lugaresi M; Molinari C; Söderström H; Räsänen J; D'Errico A; Fiocca R; Seri M; Krishnadath KK; Bonora E; Mattioli S
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00202. PubMed ID: 33094962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]